Cobalt Capital Management, Inc. Bausch Health Companies Inc. Transaction History

Cobalt Capital Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $5.39 Million - $6.93 Million	-249,500 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $2.07 Million - $2.61 Million	-90,000 Reduced 26.51%	249,500 $6.89 Million
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $4.02 Million - $4.82 Million	-160,500 Reduced 32.1%	339,500 $9.46 Million
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $1.93 Million - $2.31 Million	70,500 Added 16.41%	500,000 $14.7 Million
Q1 2021 May 17, 2021	BUY	$21.37 - $34.38 $2.39 Million - $3.85 Million	112,000 Added 35.28%	429,500 $13.6 Million
Q4 2020 Feb 16, 2021	BUY	$15.31 - $21.12 $4.86 Million - $6.71 Million	317,500 New	317,500 $6.6 Million

272

280M

5.68M

17.4M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.33B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Cobalt Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Cobalt Capital Management, Inc. with notifications on news.